학술논문
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases.
Document Type
Article
Author
Ursini, Francesco; Ruscitti, Piero; Raimondo, Vincenzo; De Angelis, Rossella; Cacciapaglia, Fabio; Pigatto, Erika; Olivo, Domenico; Di Cola, Ilenia; Galluccio, Felice; Francioso, Francesca; Foti, Rosario; Tavoni, Antonio Gaetano; D'Angelo, Salvatore; Campochiaro, Corrado; Motta, Francesca; De Santis, Maria; Bilia, Silvia; Bruno, Caterina; De Luca, Giacomo; Visentini, Marcella
Source
Subject
*COVID-19 vaccines
*SYNDROMES
*GIANT cell arteritis
*ANTIHISTAMINES
*COUGH
*SYMPTOMS
*MULTISYSTEM inflammatory syndrome
*
*
*
*
*
*
Language
ISSN
0770-3198
Abstract
Mean time from vaccine administration to clinical manifestations onset was 9 days (range 1-28); most patients 16 (53.3%) received the BNT162b2 vaccine. Interestingly, amongst systemic AEs, arthralgia is one of the most common [[2]] and only isolated cases [[6]-[9]] of inflammatory rheumatic diseases developed after COVID-19 vaccine administration have been described to date. [Extracted from the article]